首页> 外文期刊>Biomarkers >Tissue-based miRNA mapping in alcoholic liver cirrhosis: different profiles in cirrhosis with or without hepatocellular carcinoma
【24h】

Tissue-based miRNA mapping in alcoholic liver cirrhosis: different profiles in cirrhosis with or without hepatocellular carcinoma

机译:酒精性肝硬化中的组织米兰映射:肝硬化中的不同谱不同肝细胞癌

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Context: Alcoholic liver cirrhosis is a significant risk factor for the development of hepatocellular carcinoma (HCC). The importance of tumour-associated cirrhosis in the development or progression of HCC is not understood. MiRNAs are important regulators for HCC development, but their role in HCC due to alcoholic liver cirrhosis is unclear.Objective: The aim of this study is the detection of miRNA expression in alcoholic liver cirrhosis, tumour-associated cirrhosis, and HCC.Materials and methods: We analysed the differences in the miRNA profiles of HCC, tumour-associated cirrhosis, and cirrhosis without HCC samples from 30 patients who underwent liver transplantation because of alcoholic liver disease.Results: Microarray analyses revealed 40 significantly differentially expressed miRNAs between HCC tissue and tumour-associated cirrhosis tissue. Furthermore, the microarray analysis discovered 56 differentially expressed miRNAs in tumour-associated cirrhosis and cirrhosis without HCC.Discussion: The differences of miRNA profile in alcoholic liver cirrhosis with and without HCC could improve understanding of HCC development, as well as lead to a new diagnostic tool in HCC screening.Conclusion: We were able to show for the first time, the differences of miRNA profile as promising biomarker in HCC, tumour-associated cirrhosis, and cirrhosis without HCC in context of alcoholic liver disease
机译:摘要背景:酒精性肝硬化是肝细胞癌(HCC)发展的重要风险因素。肿瘤相关肝硬化在HCC发展或进展中的重要性尚未理解。 miRNA是HCC开发的重要调节因素,但它们在HCC引起的含酒精肝硬化的作用不清楚。目的:本研究的目的是检测酒精性肝硬化,肿瘤相关的肝硬化和HCC中的miRNA表达:我们分析了HCC,肿瘤相关性肝硬化和肝硬化的miRNA谱的差异,没有HCC样品,由于酒精性肝病接受肝移植的30名患者。结果:微阵列分析显示了HCC组织和肿瘤之间的显着差异表达miRNA - 分配的肝硬化组织。此外,微阵列分析发现了56种差异表达的肿瘤相关的肝硬化和肝硬化的肝硬化,没有HCC.Discssion:在没有HCC和没有HCC的无酒精肝硬化中的miRNA型谱的差异可以提高对HCC开发的理解,以及导致新的诊断HCC筛选中的工具。结论:我们能够首次表现出MiRNA谱在HCC,肿瘤相关的肝硬化和肝硬化中作为有前途的生物标志物的差异,在酒精性肝病的背景下没有HCC

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号